← FDA DRUG APPROVALS

FDA ANDA · ANDA063016

CEFAZOLIN SODIUM

Sponsor: TEVA PHARMS

APPLICATION
ANDA063016
TYPE
ANDA
ORIGINAL APPROVAL
1989-03-14
LATEST ACTION
1994-10-21
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

CEFAZOLIN SODIUMDiscontinued
CEFAZOLIN SODIUM EQ 1GM BASE/VIAL · INJECTABLE · INJECTION
CEFAZOLIN SODIUMDiscontinued
CEFAZOLIN SODIUM EQ 250MG BASE/VIAL · INJECTABLE · INJECTION
CEFAZOLIN SODIUMDiscontinued
CEFAZOLIN SODIUM EQ 500MG BASE/VIAL · INJECTABLE · INJECTION

Approval history

1994-10-21Labeling · Supplement 3AP
1993-03-10Labeling · Supplement 2AP
1990-02-22Manufacturing (CMC) · Supplement 1AP
1989-03-14OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →